Cardiac biomarkers: a contemporary status report

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature Clinical Practice Cardiovascular Medicine

• Publication date

  2006-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ncpcardio0405PMID 16391615
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ischemia Modified Albumin for the Assessment of Patients Presenting to the Emergency Department With Acute Chest Pain But Normal or Nondiagnostic 12-lead Electrocardiograms and Negative Cardiac Troponin T

  2006cited by this paper
• C-reactive protein levels and outcomes after statin therapy.

  2005cited by this paper
• N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.

  2005cited by this paper
• Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.

  2005cited by this paper
• B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation.

  2005cited by this paper
• B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure.

  2004cited by this paper
• B-Type Natriuretic Peptide: The Level and the Drug— Partners in the Diagnosis and Management of Congestive Heart Failure

  2004cited by this paper
• Inflammation and Atherosclerosis

  2004cited by this paper
• Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia.

  2004cited by this paper
• Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.

  2004cited by this paper
• Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T.

  2004cited by this paper
• A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction.

  2004cited by this paper
• Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients.

  2004cited by this paper
• Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus.

  2004cited by this paper
• B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.

  2004cited by this paper
• Plasma adiponectin levels and risk of myocardial infarction in men.

  2004cited by this paper
• Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.

  2004cited by this paper
• Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

  2004cited by this paper
• Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

  2004cited by this paper
• Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.

  2004cited by this paper
• Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

  2004cited by this paper
• Prognostic value of placental growth factor in patients with acute chest pain.

  2004cited by this paper
• Future of Biomarkers in Acute Coronary Syndromes Moving Toward a Multimarker Strategy

  2003cited by this paper
• Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

  2003cited by this paper
• B-type natriuretic peptide in cardiovascular disease.

  2003cited by this paper
• N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.

  2003cited by this paper
• Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes

  2003cited by this paper
• Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.

  2003cited by this paper
• Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes.

  2003cited by this paper
• Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes

  2003cited by this paper
• Soluble CD40L: Risk Prediction After Acute Coronary Syndromes

  2003cited by this paper
• Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome.

  2003cited by this paper
• Soluble CD40 ligand in acute coronary syndromes.

  2003cited by this paper
• Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.

  2003cited by this paper
• Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy).

  2002cited by this paper
• Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes: Ready for Clinical Application?

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes

  2002cited by this paper
• ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients

  2002cited by this paper
• Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

  2002cited by this paper
• Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide

  2002cited by this paper
• Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy.

  2001cited by this paper
• The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

  2001cited by this paper
• The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis.

  2001cited by this paper
• Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study.

  2001cited by this paper
• Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.

  2001cited by this paper
• Bedside Multimarker Testing for Risk Stratification in Chest Pain Units: The Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) Study

  2001cited by this paper
• Bedside Multimarker Testing for Risk Stratification in Chest Pain Units: The Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) Study

  2001cited by this paper
• Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.

  2001cited by this paper
• Chest pain centers: diagnosis of acute coronary syndromes.

  2000cited by this paper
• CARDIAC-SPECIFIC TROPONIN I LEVELS TO PREDICT THE RISK OF MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES

  2000cited by this paper
• Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.

  2000cited by this paper
• Transient increase in plasma brain (b‐type) natriuretic peptide after percutaneous transluminal coronary angioplasty

  2000cited by this paper
• Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.

  2000cited by this paper
• Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy.

  2000cited by this paper
• Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Independent prognostic value of elevated C-reactive protein in unstable angina.

  1999cited by this paper
• Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.

  1999cited by this paper
• Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events.

  1999cited by this paper
• C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy

  1998cited by this paper
• Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris.

  1998cited by this paper
• C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

  1998cited by this paper
• Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase.

  1997cited by this paper
• C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction.

  1997cited by this paper
• Elevated levels of interleukin-6 in unstable angina.

  1996cited by this paper
• Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

  1996cited by this paper
• Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris.

  1995cited by this paper
• Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction.

  1995cited by this paper
• Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department.

  1994cited by this paper
• Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I.

  1994cited by this paper
• Relationship between plasma level of brain natriuretic peptide and myocardial infarct size.

  1994cited by this paper
• Diagnostic Efficiency of Troponin T Measurements in Acute Myocardial Infarction

  1991cited by this paper

• From cardiac injury to omics signatures: a narrative review on biomarkers in septic cardiomyopathy

  2025influential citation
• Nanocatalytic antioxidation synergizes cardioprotection and antifibrosis in cardiac injury

  2025cites this paper
• (Myocardium Remodelling: From Adaptation Mechanisms to Heart Failure Development)

  2024cites this paper
• Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi‐heart study

  2023cites this paper
• Colon Polyps and Colorectal Cancer

  2021influential citation
• Kardiale Umfelddiagnostik bei Gefäßoperationen und Gefäßinterventionen

  2020cites this paper
• Aptamers in nanostructure-based electrochemical biosensors for cardiac biomarkers and cancer biomarkers: A review.

  2020cites this paper
• Accuracy of methods for diagnosing heart diseases in cats

  2020cites this paper
• Cardiac Assessment in Noncardiac Surgery

  2020cites this paper
• Hartfalen

  2020cites this paper
• Pre-operative Cardiovascular Evaluation in elective Noncardiac Surgery, Risk Scores, and Managerial Insight for Patients with Different Cardiac Morbidities

  2020cites this paper
• Postoperative Myocardial Injury Does Not Predict Early and 1-Year Mortality After Living Donor Liver Transplantation.

  2019cites this paper
• Osteopontin – a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease

  2019cites this paper
• Quantitative Temporal Analysis of Protein Dynamics in Maladaptive Cardiac Remodeling

  2018cites this paper
• Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study

  2018cites this paper
• N-terminal-pro brain natriuretic peptides in dogs and cats: A technical and clinical review

  2017cites this paper
• Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy.

  2017cites this paper
• Restoration of Circulating MFGE8 (Milk Fat Globule-EGF Factor 8) Attenuates Cardiac Hypertrophy Through Inhibition of Akt Pathway

  2017cites this paper
• Differential Expression of Circadian Genes in Leukemia and a Possible Role for Sirt1 in Restoring the Circadian Clock in Chronic Myeloid Leukemia

  2017cites this paper
• Clinical indices and biomarkers for perioperative cardiac risk stratification: an update.

  2017cites this paper
• The Cardiac Clock

  2016cites this paper
• Proteins with a twist : torsion profiling of proteins at the single molecule level

  2016cites this paper
• Usefulness of serum cardiac troponin I concentration as a marker of survival of harbor seal (Phoca vitulina) pups during rehabilitation.

  2016cites this paper
• Circadian Clocks: Role in Health and Disease

  2016cites this paper
• Looking for the early marker of renal injury

  2015cites this paper
• Effects of Oral Administration of Cnidoscolus aconitifolius Leaf Extract (Chaya Tea) on Biomarkers of Cardiovascular System of Wistar Albino Rats

  2015cites this paper
• Therapeutic applications of circadian rhythms for the cardiovascular system

  2015cites this paper
• Review on cardiovascular risk prediction.

  2015cites this paper
• NT-proBNP and the risk of incident hypertension: is change over time a better predictor than baseline value?

  2015cites this paper
• [Preoperative pulmonary function analysis and cardiorespiratory risk assessment: the current standard].

  2014cites this paper
• ESC / ESA Guidelines on non-cardiac surgery : cardiovascular assessment and management

  2014cites this paper
• 2014 ESC/ESA Guidelines on Non-cardiac Surgery: Cardiovascular Assessment and Management

  2014cites this paper
• 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

  2014cites this paper
• Grupo de Trabajo Conjunto sobre cirugía no cardiaca: Evaluación y manejo cardiovascular de la Sociedad Europea de Cardiología (ESC) y la European Society of Anesthesiology (ESA)

  2014cites this paper
• Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery

  2014cites this paper
• ESC / ESAGuidelines on non-cardiac surgery : cardiovascular assessment andmanagement

  2014cites this paper
• [2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment andmanagement].

  2014cites this paper
• 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

  2014cites this paper
• Cardiac evaluation and management before vascular surgery

  2014cites this paper
• Changes in Renal Function in Congestive Heart Failure

  2013cites this paper
• Perioperative evaluation of cardiac surgical risk: particularities in the emergency surgery – from the guidelines to the clinical practice

  2013cites this paper
• 8. Cardiac Biomarkers

  2013cites this paper
• Inflammatory markers in heart failure: hype or hope?

  2013cites this paper
• ZnS-nanocrystals/polypyrrole nanocomposite film based immunosensor

  2012cites this paper
• Biomarcadores de la falla cardiaca en pequeños animales

  2012cites this paper
• HMGB1 is an independent predictor of death and heart transplantation in heart failure

  2012cites this paper
• Risk Stratification by Cardiac Biomarkers following Emergency Gastrointestinal Surgery

  2011cites this paper
• Decreased serine207 phosphorylation of troponin T as a biomarker for left ventricular remodelling after myocardial infarction.

  2011cites this paper
• Concentración sérica de CA 125 en pacientes pluripatológicos con insuficiencia cardiaca

  2011cites this paper
• Acute kidney injury biomarkers: renal angina and the need for a renal troponin I

  2011cites this paper
• GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY

  2010cites this paper
• Future Frontiers in Heart Failure

  2010cites this paper
• English springer spaniels with significant bradyarrhythmias--presentation, troponin I and follow-up after pacemaker implantation.

  2010cites this paper
• Comprehensive Peroxidase-Based Hematologic Profiling for the Prediction of 1-Year Myocardial Infarction and Death

  2010cites this paper
• Decreased Serine 207 phosphorylation of troponin T as a biomarker for left ventricular remodelling after myocardial infarction

  2010cites this paper
• Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs.

  2010cites this paper
• Use of biomarkers in evaluation of patients with heart failure.

  2010cites this paper
• Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure.

  2010cites this paper
• Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the Europe

  2010cites this paper
• What does an Elevated N-terminal Pro-brain Natriuretic Peptide (NT-pro-BNP) Mean in my Renal Patient?

  2010cites this paper
• Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery

  2009cites this paper
• Cantilever biosensors in drug discovery

  2009influential citation
• The future of drug safety testing: expanding the view and narrowing the focus.

  2009cites this paper
• Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients.

  2009cites this paper
• Time-Warped Comparison of Gene Expression in Adaptive and Maladaptive Cardiac Hypertrophy

  2009cites this paper
• Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.

  2009cites this paper
• Prevalence and Prognostic Significance of Elevated &ggr;-Glutamyltransferase in Chronic Heart Failure

  2009cites this paper
• Evaluation of changes in cardiac biomarker concentrations and enzyme activities in serum after short- and long-duration transcutaneous cardiac pacing in dogs.

  2009cites this paper
• Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure.

  2009cites this paper
• Diagnosis of Acute Coronary Syndrome

  2009cites this paper
• Free PAPP-A: a Novel Marker in Acute Coronary Syndrome Patients

  2009cites this paper
• The role of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) as a prognostic marker in older people: the impact of reduced renal function

  2009cites this paper
• Guía de práctica clínica para la valoración del riesgo cardiaco preoperatorio y el manejo cardiaco perioperatorio en la cirugía no cardiaca

  2009cites this paper
• Kalp dişi cerrahide preoperatif kardiyak riskin değerlendirilmesi ve perioperatif kardiyak tedaviye ilişkin kilavuzlar Avrupa Kardiyoloji Derneği (ESC) tarafindan hazirlanan ve Avrupa Anesteziyoloji Derneği (ESA) tarafindan onaylanan Kalp Dişi Cerrahide Preoperatif Kardiyak Riskin Değerlendirilmesi

  2009cites this paper
• COMBINATORIAL PATTERN-BASED SURVIVAL ANALYSIS WITH APPLICATIONS IN BIOLOGY AND MEDICINE

  2009cites this paper
• PAPP-A : A NOVEL MARKER IN ACUTE CORONARY SYNDROME PATIENTS by Saara Wittfooth ( née Kokkala )

  2009cites this paper
• Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European of Cardiology the of Anaesthesiology

  2009cites this paper
• Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European of Cardiology the of Anaesthesiology

  2009cites this paper
• Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery.

  2009cites this paper
• Osteopontin, a New Prognostic Biomarker in Patients With Chronic Heart Failure

  2008cites this paper
• Guía de práctica clínica de la sociedad europea de cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2008)

  2008cites this paper
• Perioperative Cardiac Care: from Guidelines to Clinical Practice

  2008cites this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡

  2008cites this paper
• Evaluation in the Emergency Department and Cardiac Biomarkers

  2008cites this paper
• Proteomics and cardiovascular disease: an update.

  2008cites this paper
• Carotid intima‐media thickness and markers of inflammation, endothelial damage and hemostasis

  2008cites this paper
• New cardiovascular risk markers: The race is on, but are there any winners?

  2008cites this paper
• Long-term left-ventricular-assist-device therapy is here to stay

  2008cites this paper
• B-type natriuretic peptide (BNP) and proBNP: role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders.

  2008cites this paper
• Epidemiology and risk stratification in acute heart failure.

  2008cites this paper
• Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes.

  2008cites this paper
• Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices.

  2008cites this paper
• Relevance of platelet activation in obstructive hypertrophic cardiomyopathy

  2008cites this paper
• INVESTIGATION OF INOSINE AND HYPOXANTHINE AS BIOMARKERS OF CARDIAC ISCHEMIA IN PLASMA OF NON-TRAUMATIC CHEST PAIN PATIENTS AND A RAPID ANALYTICAL SYSTEM FOR ASSESSMENT

  2008cites this paper
• Troponin targets cardiac injury: Learn about troponin levels so you can give your patient the best possible care.

  2008cites this paper
• Troponin targets cardiac injury

  2007cites this paper
• Future of Post-Genomic Cardiology

  2007cites this paper
• Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.

  2007cites this paper
• Proteomics in cardiovascular surgery.

  2007cites this paper
• An expanding role of biomarkers in acute aortic syndromes

  2006cites this paper